HighTower Advisors »

Indivior Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 83k 41.03
2026-03-31 $311k 10k 30.48

More positions owned by HighTower Advisors

Apple (AAPL)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Sharkninja Com Shs (SN)
Exxon Mobil Corporation (XOM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)

View all positions for HighTower Advisors

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Hanna Zanoni
Morgan Stanley
Two Seas Capital
Franklin Resources
Geode Capital Management
Madison Avenue Partners
Citadel Advisors
Mangrove Partners
Driehaus Capital Management
Millennium Management

View all funds holding Indivior Pharmaceuticals